These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21682977)

  • 1. Advancing the development of diagnostic tests and biomarkers for tuberculosis.
    Yasinskaya Y; Plikaytis B; Sizemore C; Sacks L
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):985-7. PubMed ID: 21682977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era.
    Perkins MD; Cunningham J
    J Infect Dis; 2007 Aug; 196 Suppl 1():S15-27. PubMed ID: 17624822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the laboratory detection of Mycobacterium tuberculosis complex and drug resistance.
    Wilson ML
    Clin Infect Dis; 2011 Jun; 52(11):1350-5. PubMed ID: 21596676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.
    McNerney R; Maeurer M; Abubakar I; Marais B; McHugh TD; Ford N; Weyer K; Lawn S; Grobusch MP; Memish Z; Squire SB; Pantaleo G; Chakaya J; Casenghi M; Migliori GB; Mwaba P; Zijenah L; Hoelscher M; Cox H; Swaminathan S; Kim PS; Schito M; Harari A; Bates M; Schwank S; O'Grady J; Pletschette M; Ditui L; Atun R; Zumla A
    J Infect Dis; 2012 May; 205 Suppl 2():S147-58. PubMed ID: 22496353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis and the expanding role of the laboratory.
    Kawamura LM; Desmond E
    MLO Med Lab Obs; 2005 Aug; 37(8):12-4, 16-8; quiz 20-1. PubMed ID: 16194009
    [No Abstract]   [Full Text] [Related]  

  • 9. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance.
    Alcaide F; Coll P
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():34-40. PubMed ID: 21420565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enabling biomarkers for tuberculosis control.
    Maertzdorf J; Weiner J; Kaufmann SH
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1140-8. PubMed ID: 22871324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance.
    Pai M; Kalantri S; Dheda K
    Expert Rev Mol Diagn; 2006 May; 6(3):423-32. PubMed ID: 16706744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis: drug resistance and future perspectives.
    Riccardi G; Pasca MR; Buroni S
    Future Microbiol; 2009 Jun; 4(5):597-614. PubMed ID: 19492969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TB diagnostic tests: how do we figure out their costs?
    Sohn H; Minion J; Albert H; Dheda K; Pai M
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):723-33. PubMed ID: 19681700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis.
    Palomino JC; Martin A; Von Groll A; Portaels F
    J Microbiol Methods; 2008 Oct; 75(2):161-6. PubMed ID: 18627779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General and advanced diagnostic tools to detect Mycobacterium tuberculosis and their drug susceptibility: a review.
    Gazi MA; Islam MR; Kibria MG; Mahmud Z
    Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):851-61. PubMed ID: 25560709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phage amplified biologically assay and its application in rapid detection of Mycobacterium tuberculosis].
    Hu ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):850-2. PubMed ID: 15730788
    [No Abstract]   [Full Text] [Related]  

  • 17. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for TB treatment response: challenges and future strategies.
    Walzl G; Ronacher K; Djoba Siawaya JF; Dockrell HM
    J Infect; 2008 Aug; 57(2):103-9. PubMed ID: 18649943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
    Matee M; Mfinanga S; Holm-Hansen C
    APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation of Mycobacterium tuberculosis with primary resistance to chemotherapeutic agents in patients with HIV infection].
    Sesma P; Esteban J; Gegundez MI; Manrique A; Espinosa P; Fernández-Guerrero ML
    Enferm Infecc Microbiol Clin; 1992; 10(7):416-20. PubMed ID: 1450261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.